BACKGROUND: Hepatic fibrosis is a necessary step in the development of hepatic cirrhosis. In this study we used lentiviral vector-mediated transfection technology to evaluate the effect of peroxisome proliferator-activated receptor gamma (PPAR-γ) on rat hepatic fibrosis.
METHODS: Hepatic fibrosis in rats was induced by CCl4 for 2 weeks (early fibrosis) and 8 weeks (sustained fibrosis). The rats were randomly divided into four groups: normal control, fibrosis, blank vector, and PPAR-γ. They were infected with the recombinant lentiviral expression vector carrying the rat PPAR-γ gene by portal vein injection. The liver of the rats was examined histologically and hydroxyproline was assessed. In vitro primary hepatic stellate cells (HSCs) were infected with the recombinant lentiviral expression vector carrying the rat PPAR-γ gene. The status of HSC proliferation was measured by the MTT assay. The protein levels of PPAR-γ, α-smooth muscle actin (α-SMA) and type I collagen expression were evaluated by the Western blotting method.
RESULTS: In vitro studies revealed that expression of PPAR-γ inhibited expression of α-SMA and type I collagen in activated HSCs (P<0.01) as well as HSC proliferation (P<0.01). In vivo experiments indicated that in the early hepatic fibrosis group, the hydroxyproline content and the level of collagen I protein in the liver in the PPAR-γ transfected group were not significantly different compared to the hepatic fibrosis group and the blank vector group; whereas the expressions of PPAR-γ and α-SMA were different compared to the hepatic fibrosis group (P<0.01). In the sustained hepatic fibrosis group, there were significant differences in the hydroxyproline content and the expression of PPAR-γ, α-SMA, and type I collagen between each group.
CONCLUSION: PPAR-γ can inhibit HSC proliferation and hepatic fibrosis, and suppress α-SMA and type I collagen expression.